Michael Leibowitz

Chief Scientific Officer at 20/20 Gene Systems

Dr. Lebowitz has more than 18 years of experience in biomedical research within the biotech industry having previously served as Vice President of Research at Ariadne Diagnostics LLC. He has been directly involved in the commercial launch of six cancer diagnostic tests and the research leading up to a pharmaceutical ind approval. Dr. Lebowitz holds a Ph.D. from the Johns Hopkins University School of Medicine in Biochemistry Cellular and Molecular Biology where he subsequently completed a three-year fellowship in Immunology in the Department of Pathology Division of Immunopathology


Org chart

No direct reports

Teams


Offices

This person is not in any offices


20/20 Gene Systems

20/20 GeneSystems (‘20/20’) was founded in May of 2000 to develop and promote an innovative proteomics product line that provides drug


Industries

Employees

11-50

Links